Molecular Characterization of Gene-Mediated Resistance and Susceptibility of ESKAPE Clinical Isolates to Cistus monspeliensis L. and Cistus salviifolius L. Extracts

Table 4

Yields of C. salviifolius and C. monspeliensis extractions.

Cistus species	Solvent used	Yield with maceration (%)	Extracts ID	Yield with Soxhlet (%)	Extracts ID
C. monspeliensis	Methanol	28.8	CCMM	56.66	CCMS
	Hexane	1.5	F1CMM	1.2	F1CMS
	Dichloromethane	4.74	F2CMM	8.4	F2CMS
	Ethyl acetate	2.25	F3CMM	12	F3CMS
	n-butanol	6.25	F4CMM	16	F4CMS
	Remaining aqueous	13	F5CMM	18.8	F5CMS
C. salviifolius	Methanol	27.9	CCSM	31	CCSS
	Hexane	0.7	F1CSM	1	F1CSS
	Dichloromethane	0.7	F2CSM	1.33	F2CSS
	Ethyl acetate	1	F3CSM	3.66	F3CSS
	n-butanol	7	F4CSM	3.33	F4CSS
	Remaining aqueous	16.7	F5CSM	20.3	F5CSS

CCMM: crude CM from maceration; CCMS: crude CM from Soxhlet; F1CMM: hexane fraction of CM from maceration; F1CMS: hexane fraction of CM from Soxhlet; F2CMM: dichloromethane fraction of CM from maceration; F2CMS: dichloromethane fraction of CM from Soxhlet; F3CMM: ethyl acetate fraction of CM from maceration; F3CMS: ethyl acetate fraction of CM from Soxhlet; F4CMM: n-butanol fraction of CM from maceration; F4CMS: n-butanol fraction of CM from Soxhlet; F5CMM: remaining aqueous of CM from maceration; F5CMS: remaining aqueous of CM from Soxhlet; CCSM: crude CS from maceration; CCSS: crude CS from Soxhlet; F1CSM: hexane fraction of CS from maceration; F1CSS: hexane fraction of CS from Soxhlet; F2CSM: dichloromethane fraction of CS from maceration; F2CSS: dichloromethane fraction of CS from Soxhlet; F3CSM: ethyl acetate fraction of CS from maceration; F3CSS: ethyl acetate fraction of CS from Soxhlet; F4CSM: n-butanol fraction of CS from maceration; F4CSS: n-butanol fraction of CS from Soxhlet; F5CSM: remaining aqueous fraction of CS from maceration; F5CSS: remaining aqueous fraction of CS from Soxhlet.